On June 14, 2021, Royal Philips’ subsidiary, Philips Respironics, initiated a voluntary recall notification* for certain sleep and respiratory care products to address identified potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam in these devices. Following the substantial ramp-up of its production, service, and repair capacity, the repair and replacement program in the U.S. and several other markets is under way. Philips Respironics has also been conducting a comprehensive test and research program on the PE-PUR foam to better assess and scope potential patient health risks related to possible emission of particulates from degraded foam and certain Volatile Organic Compounds (VOCs).
Finalize recall and testing
Manage litigation, DoJ investigation
483 remediation and clarity on proposed Consent Decree
~99% of recall units produced; >4.5M units1 w/ patients and care providers Completed all testing and analysis for DS1, DS Go and System One devices
Provision related to anticipated resolution of the economic loss class action in the US
483 remediation in progress
Manage impact of proposed Consent Decree
Manage litigation, DoJ investigation
Gradually restore position
1. New replacement devices and repair kits required for the remediation of the total currently registered affected devices.
Leandro Mazzoni Head of Investor Relations
Derya Guzel Investor Relations Director
Dorin Danu Investor Relations Director
Rashiq Muhaimen Investor Relations Manager – ESG related topics
Monique Corporate Access Manager
van der Heiden
Disclaimers * This is a recall notification for the US only, and a field safety notice for the rest of the world
You are about to visit a Philips global content page
Continue